July 2026
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the efficacy and safety of empagliflozin in adults with type 2 diabetes who were not adequately controlled on metformin and sitagliptin. Results indicated significant reductions in HbA1c and body weight with empagliflozin treatment.
Interventions
Empagliflozin
Outcomes
Adverse events incidenceBody weightFasting Plasma Glucose (FPG)+3 more
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the efficacy and safety of SGLT2 and DPP-4 inhibitors in adolescents and young adults with Type 2 diabetes, finding modest reductions in HbA1c with empagliflozin.
Interventions
Dipeptidyl peptidase-4 inhibitorsEmpagliflozin
Outcomes
Body weightFasting Plasma Glucose (FPG)HbA1c+1 more
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the effects of an empowerment-based interprofessional follow-up intervention on individuals with Type 2 diabetes, finding significant improvements in glycemic control, body weight, and waist circumference.
Interventions
Empowerment-based interprofessional follow-up intervention
Outcomes
Body weightHbA1cPatient Activation+1 more
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the outcomes of endoscopic partial jejunal diversion using a self-assembling magnetic anastomosis system over 36 months, finding significant weight loss and improvements in glycemic control.
Interventions
Partial Jejunal Diversion (PJD) using Incisionless Magnetic Anastomosis System (IMAS)
Outcomes
Adverse events incidenceBody weightHbA1c+2 more
Added to Dediabetes Jul 18, 2026RCTs
This study investigated endovascular denervation targeting the celiac and hepatic arteries in patients with poorly controlled type 2 diabetes, finding significant reductions in HbA1c levels.
Interventions
Endovascular denervation (EDN) targeting the celiac and hepatic arteries
Outcomes
Adverse events incidenceBlood pressure reductionDevice- and/or procedure-related major adverse events (MAEs)+2 more
Added to Dediabetes Jul 18, 2026RCTs
This study investigated the effects of essential phospholipids on liver health in patients with metabolic dysfunction-associated steatotic liver disease, finding significant improvements in hepatic steatosis and quality of life.
Interventions
Essential Phospholipids (EPL)
Outcomes
Controlled attenuation parameterHbA1cQuality of life
Added to Dediabetes Jul 18, 2026RCTs
A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.
Interventions
Exercise therapy
Outcomes
C-reactive proteinChange in IL-1ra levelsFasting Plasma Glucose (FPG)+8 more
Added to Dediabetes Jul 18, 2026RCTs
A structured family and peer support intervention improved glycemic control in patients with type 2 diabetes.
Interventions
Structured family and peer support intervention
Outcomes
HbA1cQuality of lifeSelf-management scores+1 more
Added to Dediabetes Jul 18, 2026RCTs
This study evaluated the impact of financial incentives and social feedback on physical activity in adults with newly diagnosed Type 2 diabetes, finding significant increases in daily step count and physical activity levels.
Interventions
Financial incentive and social comparison feedbackStepped care diabetes prevention program with financial incentives
Outcomes
Body weightDaily step countHbA1c+3 more
Added to Dediabetes Jul 18, 2026RCTs
This pilot randomized controlled trial evaluated flash glucose monitoring in Indigenous Australians with type 2 diabetes, finding no significant differences in key outcomes.
Interventions
Freestyle Libre 1 FGM use
Outcomes
Blood glucoseHbA1cNumber of hypoglycaemic episodes+1 more